Clinical Trial Update: Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of oje milast (OGLEmilast) in COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Oglemilast (oglemilast)

Snippet

Sponsor: Forest Laboratories | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED